"Section 232" national security levies won't apply to a wide array of drugs, meaning the "overall threat to the sector should be low," according to one analyst.
Trump revives pharma tariffs with 100% charges, but leaves loopholes
HOT NEWS
Strategic Synergy: Integrating Medical Affairs and Commercial…
Join this live webinar to learn more. The strategic alignment between Medical Affairs and Commercial…
تُظهر الدراسة أن وجبة الإفطار الغنية بالجوز من الممكن أن تساعد في تعزيز قوة دماغك
California Walnut كما أظهر بحثٌ جديد أن تناول الجوز في وجبة الإفطار يمكن أن يحسّن…
Arab Newswire Provides Press Release Distribution in Arabic
Arab Newswire - Press release distribution to media in MENA/GCC Regions Newswire expands reach with…